Advertisement

Pharmacy World & Science

, 32:19 | Cite as

Hyponatremia associated with paroxetine induced by sodium-restricted diet and hypotonic saline

  • Tetsuro KoideEmail author
  • Toru Wakabayashi
  • Toru Matsuda
  • Shinichiro Horiike
  • Keiko Watanabe
Case Report

Abstract

Case description An 89-year-old woman taking paroxetine was admitted to our hospital for femoral neck fracture; her diet became sodium restricted due to hypertension. After admission, the femoral head replacement was performed and hypotonic saline was administered over 2 days. On the fifth day after the operation, severe hyponatremia was observed and treated with oral fluid restriction, furosemide, sodium chloride and paroxetine discontinuance. In a few days, serum sodium concentration returned to baseline level. Conclusions Besides risk factors for SIADH, a sodium-restricted diet and infusions of hypotonic saline in the perioperative period should be considered risk factors for SIADH associated with paroxetine.

Keywords

Hyponatremia Hypotonic saline Paroxetine Sodium-restricted diet 

References

  1. 1.
    Skerritt U, Evans R, Montgomery SA. Selective serotonin reuptake inhibitors in older people. A tolerability perspective. Drug Aging. 1997;10:209–18.CrossRefGoogle Scholar
  2. 2.
    Odeh M, Seligmann H, Oliven A. Severe life-threatening hyponatremia during paroxetine therapy. J Clin Pharmacol. 1999;39:1290–1.CrossRefPubMedGoogle Scholar
  3. 3.
    Bez Y, Aktolga S, Balci M, Nurmedov S, Topçuoglu V. Citalopram-induced SIADH in a hypertensive patient on salt restricted diet. J Psychopharmacol. 2007;21:665–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Tolias CM. Severe hyponatremia in elderly patients: cause for concern. Ann R Coll Surg Engl. 1995;77:346–8.PubMedGoogle Scholar
  5. 5.
    Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40:1618–22.CrossRefPubMedGoogle Scholar
  6. 6.
    Kubota T, Miyata A. Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine. J Anesth. 2006;20:126–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Arinzon ZH, Lehman YA, Fidelman ZG, Krasnyansky II. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother. 2002;36:1175–7.Google Scholar
  8. 8.
    Ayus JC, Arieff AI. Brain damage and postoperative hyponatremia: the role of gender. Neurology. 1996;46:323–8.PubMedGoogle Scholar
  9. 9.
    Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.PubMedGoogle Scholar
  10. 10.
    Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatremia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Lane N, Allen K. Hyponatremia after orthopaedic surgery. Br Med J. 1999;318:1363–4.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Tetsuro Koide
    • 1
    Email author
  • Toru Wakabayashi
    • 2
  • Toru Matsuda
    • 2
  • Shinichiro Horiike
    • 3
  • Keiko Watanabe
    • 1
  1. 1.Department of PharmacyKuwana Municipal HospitalKuwanaJapan
  2. 2.Department of OrthopedicsKuwana Municipal HospitalKuwanaJapan
  3. 3.Department of Internal MedicineKuwana Municipal HospitalKuwanaJapan

Personalised recommendations